Osseointegration Implants Market Report by Product (Bone-Anchored Prostheses, Dental Implants), Material (Metallic, Ceramic, Polymeric, Biomaterials), End User (Hospitals, Ambulatory Surgical Centers, Dental Clinics), and Region 2024-2032
골 결합형 임플란트 세계 시장 규모는 2023년 67억 5,490만 달러에 달했습니다. 향후 IMARC Group은 2032년까지 시장 규모가 108억 6,980만 달러에 달하고, 2024-2032년 5.3%의 연평균 성장률(CAGR)을 나타낼 것으로 예상하고 있습니다.
골유착 임플란트는 조골세포와 지지 결합조직이 이동할 수 있는 구멍이 있는 골내 임플란트의 일종입니다. 세라믹, 생체적합성 고분자, 티타늄, 크롬, 탄탈럼, 코발트, 스테인리스강 등의 금속을 사용하여 제조됩니다. 이러한 임플란트는 결합조직을 매개하지 않고 뼈와 임플란트를 직접 구조적으로 결합시켜 새로 형성되는 라멜라 뼈의 성장과 상호 유도를 가능하게 합니다. 또한 기존 수술법에 비해 부작용이 적고 안정성이 향상되며, 수술 후 회복 시간이 단축됩니다. 그 결과, 골유착 임플란트는 치과용 임플란트, 골고정 보청기, 인공와우, 척추기구, 인공 무릎관절 등에 널리 사용되고 있습니다.
골유착형 임플란트 시장 동향
고령화로 인한 치과 질환 증가, 불소에 대한 불충분한 노출, 구강 위생 상태의 악화가 시장 성장을 가속하는 주요 요인으로 작용하고 있습니다. 또한 교통사고로 인한 사망자 수 증가와 골관절염 및 류마티스 관절염 환자 증가로 인해 인공관절 치환술 및 무릎 인공관절 치환술에 대한 필요성이 증가하고 있습니다. 이는 최소침습수술(MIS)에 대한 소비자의 선호도 변화와 맞물려 시장 성장을 가속하고 있습니다. 또한 건강에 해로운 식습관, 좌식 생활습관, 과도한 음주, 흡연 등으로 인해 비만과 퇴행성 척추 질환과 같은 만성질환이 널리 퍼져 있는 것도 골 결합형 임플란트에 대한 수요를 증가시키고 있습니다. 또한 주요 기업은 제품 포트폴리오를 확장하고 경쟁력을 유지하기 위해 혁신적인 제품 출시를 위한 연구개발 활동에 많은 투자를 하고 있습니다. 미용 치과의 대중화, 의료 인프라 개선, 소비자의 가처분 소득 증가, 정부 지원책, 유리한 상환 정책 등 다른 요인들도 시장 전망을 밝게 하고 있습니다.
이 보고서에서 다룬 주요 질문
- 2023년 세계 골유착형 임플란트 시장 규모는?
- 2024-2032년 세계 골유착형 임플란트 시장의 예상 성장률은?
- 세계 골유착형 임플란트 시장을 촉진하는 주요 요인은?
- COVID-19가 세계 골유착 임플란트 시장에 미치는 영향은?
- 세계 골유착형 임플란트 시장의 제품별 시장 현황은?
- 세계 골유착형 임플란트 시장의 최종사용자별 분석은?
- 세계 골유착형 임플란트 시장의 주요 지역은?
- 세계 골유착형 임플란트 시장의 주요 기업은?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 개요
제4장 서론
제5장 세계의 골유착 임플란트 시장
- 시장 개요
- 시장 실적
- COVID-19의 영향
- 시장 예측
제6장 시장 내역 : 제품별
제7장 시장 내역 : 재료별
제8장 시장 내역 : 최종사용자별
제9장 시장 내역 : 지역별
- 북미
- 아시아태평양
- 유럽
- 독일
- 프랑스
- 영국
- 이탈리아
- 스페인
- 러시아
- 기타
- 라틴아메리카
- 중동 및 아프리카
제10장 SWOT 분석
제11장 밸류체인 분석
제12장 Porter's Five Forces 분석
- 개요
- 바이어의 교섭력
- 공급 기업의 교섭력
- 경쟁의 정도
- 신규 진출업체의 위협
- 대체품의 위협
제13장 가격 분석
제14장 경쟁 구도
- 시장 구조
- 주요 기업
- 주요 기업의 개요
- Bicon LLC
- CONMED Corporation
- Demant A/S
- Dentsply Sirona Inc.
- Envista Holdings Corporation
- Henry Schein Inc.
- Institut Straumann AG
- Integrum AB
- Medtronic plc
- NuVasive Inc.
- Osstem Implant Co. Ltd.
- Smith & Nephew plc
- Stryker Corporation
- Zimmer Biomet
KSA
The global osseointegration implants market size reached US$ 6,754.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 10,869.8 Million by 2032, exhibiting a growth rate (CAGR) of 5.3% during 2024-2032.
Osseointegration implants refer to a type of endosteal implants that contain pores in which osteoblasts and supporting connective tissues can migrate. They are manufactured using ceramics, biostable polymers, and metals, such as titanium, chromium, tantalum, cobalt, and stainless steel. They allow a direct structural connection between the bone and implant without interposed connective tissues and ingrowth or interdigitation of the newly formed lamellar bone. They also offer fewer side effects, enhanced stability, and reduced post-surgery recovery time than traditional procedures. As a result, osseointegration implants are widely used for dental implants, bone-anchored hearing aids, endoprostheses, spinal instrumentation hardware, and knee and joint replacement.
Osseointegration Implants Market Trends:
The increasing cases of dental disorders on account of the aging population, inadequate exposure to fluoride, and poor oral hygiene represent the primary factors driving the market growth. Additionally, the rising fatal road traffic accidents and the growing number of individuals suffering from osteoarthritis and rheumatoid arthritis have strengthened the need for joint and knee replacement surgeries. This, in line with the shifting consumer preferences toward minimally invasive surgeries (MIS), is catalyzing the market growth. Besides this, the widespread prevalence of chronic diseases, such as obesity and degenerative spinal conditions, due to unhealthy eating habits, sedentary lifestyles, high alcohol consumption, and smoking is augmenting the demand for osseointegration implants. Furthermore, the leading players are heavily investing in research and development (R&D) activities to launch innovative product variants to expand their product portfolio and maintain a competitive edge. Other factors, including the rising adoption of cosmetic dentistry, improving healthcare infrastructure, inflating consumer disposable incomes, supportive government initiatives, and favorable reimbursement policies, are also creating a positive market outlook.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global osseointegration implants market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, material and end user.
Breakup by Product:
Bone-Anchored Prostheses
Dental Implants
Breakup by Material:
Metallic
Ceramic
Polymeric
Biomaterials
Breakup by End User:
Hospitals
Ambulatory Surgical Centers
Dental Clinics
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bicon LLC, CONMED Corporation, Demant A/S, Dentsply Sirona Inc., Envista Holdings Corporation, Henry Schein Inc., Institut Straumann AG, Integrum AB, Medtronic plc, NuVasive Inc., Osstem Implant Co. Ltd., Smith & Nephew plc, Stryker Corporation and Zimmer Biomet.
Key Questions Answered in This Report
- 1. What was the size of the global osseointegration implants market in 2023?
- 2. What is the expected growth rate of the global osseointegration implants market during 2024-2032?
- 3. What are the key factors driving the global osseointegration implants market?
- 4. What has been the impact of COVID-19 on the global osseointegration implants market?
- 5. What is the breakup of the global osseointegration implants market based on the product?
- 6. What is the breakup of the global osseointegration implants market based on the end user?
- 7. What are the key regions in the global osseointegration implants market?
- 8. Who are the key players/companies in the global osseointegration implants market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Osseointegration Implants Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Forecast
6 Market Breakup by Product
- 6.1 Bone-Anchored Prostheses
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Dental Implants
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
7 Market Breakup by Material
- 7.1 Metallic
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Ceramic
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
- 7.3 Polymeric
- 7.3.1 Market Trends
- 7.3.2 Market Forecast
- 7.4 Biomaterials
- 7.4.1 Market Trends
- 7.4.2 Market Forecast
8 Market Breakup by End User
- 8.1 Hospitals
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Ambulatory Surgical Centers
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Dental Clinics
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 United States
- 9.1.1.1 Market Trends
- 9.1.1.2 Market Forecast
- 9.1.2 Canada
- 9.1.2.1 Market Trends
- 9.1.2.2 Market Forecast
- 9.2 Asia-Pacific
- 9.2.1 China
- 9.2.1.1 Market Trends
- 9.2.1.2 Market Forecast
- 9.2.2 Japan
- 9.2.2.1 Market Trends
- 9.2.2.2 Market Forecast
- 9.2.3 India
- 9.2.3.1 Market Trends
- 9.2.3.2 Market Forecast
- 9.2.4 South Korea
- 9.2.4.1 Market Trends
- 9.2.4.2 Market Forecast
- 9.2.5 Australia
- 9.2.5.1 Market Trends
- 9.2.5.2 Market Forecast
- 9.2.6 Indonesia
- 9.2.6.1 Market Trends
- 9.2.6.2 Market Forecast
- 9.2.7 Others
- 9.2.7.1 Market Trends
- 9.2.7.2 Market Forecast
- 9.3 Europe
- 9.3.1 Germany
- 9.3.1.1 Market Trends
- 9.3.1.2 Market Forecast
- 9.3.2 France
- 9.3.2.1 Market Trends
- 9.3.2.2 Market Forecast
- 9.3.3 United Kingdom
- 9.3.3.1 Market Trends
- 9.3.3.2 Market Forecast
- 9.3.4 Italy
- 9.3.4.1 Market Trends
- 9.3.4.2 Market Forecast
- 9.3.5 Spain
- 9.3.5.1 Market Trends
- 9.3.5.2 Market Forecast
- 9.3.6 Russia
- 9.3.6.1 Market Trends
- 9.3.6.2 Market Forecast
- 9.3.7 Others
- 9.3.7.1 Market Trends
- 9.3.7.2 Market Forecast
- 9.4 Latin America
- 9.4.1 Brazil
- 9.4.1.1 Market Trends
- 9.4.1.2 Market Forecast
- 9.4.2 Mexico
- 9.4.2.1 Market Trends
- 9.4.2.2 Market Forecast
- 9.4.3 Others
- 9.4.3.1 Market Trends
- 9.4.3.2 Market Forecast
- 9.5 Middle East and Africa
- 9.5.1 Market Trends
- 9.5.2 Market Breakup by Country
- 9.5.3 Market Forecast
10 SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Bicon LLC
- 14.3.1.1 Company Overview
- 14.3.1.2 Product Portfolio
- 14.3.2 CONMED Corporation
- 14.3.2.1 Company Overview
- 14.3.2.2 Product Portfolio
- 14.3.2.3 Financials
- 14.3.2.4 SWOT Analysis
- 14.3.3 Demant A/S
- 14.3.3.1 Company Overview
- 14.3.3.2 Product Portfolio
- 14.3.3.3 Financials
- 14.3.3.4 SWOT Analysis
- 14.3.4 Dentsply Sirona Inc.
- 14.3.4.1 Company Overview
- 14.3.4.2 Product Portfolio
- 14.3.4.3 Financials
- 14.3.4.4 SWOT Analysis
- 14.3.5 Envista Holdings Corporation
- 14.3.5.1 Company Overview
- 14.3.5.2 Product Portfolio
- 14.3.5.3 Financials
- 14.3.6 Henry Schein Inc.
- 14.3.6.1 Company Overview
- 14.3.6.2 Product Portfolio
- 14.3.6.3 Financials
- 14.3.6.4 SWOT Analysis
- 14.3.7 Institut Straumann AG
- 14.3.7.1 Company Overview
- 14.3.7.2 Product Portfolio
- 14.3.7.3 Financials
- 14.3.7.4 SWOT Analysis
- 14.3.8 Integrum AB
- 14.3.8.1 Company Overview
- 14.3.8.2 Product Portfolio
- 14.3.8.3 Financials
- 14.3.9 Medtronic plc
- 14.3.9.1 Company Overview
- 14.3.9.2 Product Portfolio
- 14.3.9.3 Financials
- 14.3.9.4 SWOT Analysis
- 14.3.10 NuVasive Inc.
- 14.3.10.1 Company Overview
- 14.3.10.2 Product Portfolio
- 14.3.10.3 Financials
- 14.3.10.4 SWOT Analysis
- 14.3.11 Osstem Implant Co. Ltd.
- 14.3.11.1 Company Overview
- 14.3.11.2 Product Portfolio
- 14.3.11.3 Financials
- 14.3.12 Smith & Nephew plc
- 14.3.12.1 Company Overview
- 14.3.12.2 Product Portfolio
- 14.3.12.3 Financials
- 14.3.12.4 SWOT Analysis
- 14.3.13 Stryker Corporation
- 14.3.13.1 Company Overview
- 14.3.13.2 Product Portfolio
- 14.3.13.3 Financials
- 14.3.13.4 SWOT Analysis
- 14.3.14 Zimmer Biomet
- 14.3.14.1 Company Overview
- 14.3.14.2 Product Portfolio
- 14.3.14.3 Financials
- 14.3.14.4 SWOT Analysis
